{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:18:59Z","timestamp":1761513539827,"version":"build-2065373602"},"reference-count":4,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.clbc.2017.02.005","type":"journal-article","created":{"date-parts":[[2017,2,17]],"date-time":"2017-02-17T07:46:10Z","timestamp":1487317570000},"page":"e165","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Molecular Subtypes and Lower Inner Quadrant Tumors in Breast Cancer: Debate Is Still Ongoing"],"prefix":"10.1016","volume":"17","author":[{"given":"Kadri","family":"Altundag","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clbc.2017.02.005_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.clbc.2016.12.011","article-title":"Poor prognosis of lower inner quadrant in lymph node negative breast cancer patients who received no chemotherapy: a study based on nationwide Korean Breast Cancer Registry Database","author":"Hwang","year":"2017","journal-title":"Clin Breast Cancer"},{"issue":"Suppl 15","key":"10.1016\/j.clbc.2017.02.005_bib2","article-title":"Tumor locations significantly affect disease free survival and overall survival","volume":"33","author":"Buyukhatipoglu","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2017.02.005_bib3","doi-asserted-by":"crossref","first-page":"394","DOI":"10.4048\/jbc.2016.19.4.394","article-title":"Prognostic significance of inner quadrant involvement in breast cancer treated with neoadjuvant chemotherapy","volume":"19","author":"Chang","year":"2016","journal-title":"J\u00a0Breast Cancer"},{"key":"10.1016\/j.clbc.2017.02.005_bib4","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s10549-016-3771-6","article-title":"Prognostic implication of the tumor location according to molecular subtypes in axillary lymph node-positive invasive ductal cancer in a Korean population","volume":"156","author":"Lim","year":"2016","journal-title":"Breast Cancer Res Treat"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820917300198?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820917300198?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:15:48Z","timestamp":1761513348000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820917300198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":4,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S1526820917300198"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2017.02.005","relation":{},"ISSN":["1526-8209"],"issn-type":[{"type":"print","value":"1526-8209"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular Subtypes and Lower Inner Quadrant Tumors in Breast Cancer: Debate Is Still Ongoing","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2017.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}